JLL Partners Completes PharmaNet Acquisition

JLL Partners has completed its tender offer for all outstanding common shares of PharmaNet Development Group Inc. (Nasdaq: PDGI), a provider of clinical development services. The deal was valued at approximately $98 million.

20 March 2009•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles